The state Department of Health Care Services (DHCS) carved out all prescription benefits from Managed Care Plans under a program called Medi-Cal Rx. All pharmacy claims should be submitted directly to the state via its pharmacy benefit manager (PBM), Prime Therapeutics, Inc.
For help with a pharmacy claim or prior authorization, please contact the Medi-Cal Rx Customer Service Center at 1.800.977.2273 or you can send an email or chat here. Agents are available 24 hours a day, seven days a week, 365 days a year.
To submit a prior authorization or an appeal for a pharmacy claim to Medi-Cal Rx, please fax 1.800.869.4325.
If the pharmacy asks for a BIN, PCN, and Group information for billing your pharmacy claims, they will be processed under: BIN 022659, PCN 6334225, Group MEDICALRX.
You may also want to visit the Medi-Cal Rx Communication page for any upcoming bulletins and news.
Medi-Cal Rx Pediatric Integration Implementation Completed as of Friday, April 25, 2025
- As of April 25, 2025, Medi-Cal Rx concluded the implementation of claims UM edits and PA requirements for all members, including members 21 years of age and younger, for all drugs / products including continuation of therapy claims.
- For more information, please refer to the Education & Outreach page on the Medi-Cal Rx Web Portal and selecting the Pediatric Integration tab.
Rite Aid Pharmacy Closures
Rite Aid filed for bankruptcy in October 2023, resulting in the closure of several locations nationwide. On May 5, 2025, Rite Aid filed for bankruptcy again and is in the process of selling assets including prescriptions, to other pharmacies.
In response, the California Department of Consumers Affairs and the California State Board of Pharmacy released a Joint Statement on May 5, 2025. The statement urges prescribers to be responsive to pharmacists' outreach regarding prescription refills and to proactively work with patients to find alternative pharmacies. The closures are expected to significantly affect timely access to prescriptions, particularly in communities where Rite Aid was the primary pharmacy.
For details about when a specific Rite Aid store will be closing, please contact the store directly.
Some Rite Aid locations plan to transfer members’ prescriptions to other pharmacies. To avoid disruption in access to therapy, pharmacy providers and prescribers should encourage members to contact their Rite Aid pharmacy to determine if they need to transfer their prescriptions or if that pharmacy location will transfer their prescriptions for them.
Prescriptions at a Rite Aid location can be transferred to any pharmacy that is contracted with Medi-Cal Rx. To find a participating pharmacy, visit the Medi-Cal Rx website.
For further details and guidance, please refer to the Medi-Cal Rx Rite Aid Closure Guidance for Providers.
DHCS VFC Pharmacy Pilot Program
The Department of Health Care Services (DHCS) is collaborating with the California Department of Public Health (CDPH) on the Vaccines for Children (VFC) Pharmacy Pilot program. DHCS will reimburse Medi-Cal enrolled pharmacy providers who provide immunization services under VFC program to VFC-eligible members in Medi-Cal. My Turn Vaccine Locator is available to find vaccine providers (including pharmacies enrolled in VFC) in a given coverage area: Vaccine Locator – My Turn CA.gov.
The VFC Program helps families by providing vaccines at no cost to medical providers who serve eligible children from birth through 18 years of age. CDC contracts with vaccine manufacturers to buy vaccines at reduced rates. Enrolled providers order federally funded vaccines through their state VFC Program and receive routine vaccines (including influenza) at no cost.
Important Links
- Medi-Cal Rx Website: Please bookmark this website and sign up for the Medi-Cal Rx Subscription Service (MCRxSS) to receive important information directly from DHCS.
- Medi-Cal Rx Provider Portal: Register to get access to beneficiary eligibility lookup, prior authorization, web claims submission, etc.
- Medi-Cal Rx Prior Authorization Requests and Appeals: Gold Coast Health Plan (GCHP) put together this information sheet about how to submit prior authorization requests and appeals to Medi-Cal Rx.
- Medi-Cal Rx Contract Drugs List (CDL): Please bookmark this website for the most up-to-date Contract Drugs List (CDL) from Medi-Cal Rx. It also includes other Covered Products Lists, such as Blood Pressure Monitoring Devices and Continuous Glucose Monitoring Systems.
- Medi-Cal Rx Drug Lookup Tool (DLT): Improved functionality to search by brand or generic drug name or NDC, and identify information about prior authorization requirements or Code I restrictions.
Additional Medi-Cal Rx Resources
- Medi-Cal Rx Bulletins & News
- Medi-Cal Rx Provider Portal
- Medi-Cal Rx Forms & Information
- Medi-Cal Rx Education & Outreach (including updates on Reinstatement)
Medi-Cal Rx News
- June 1, 2025: Diabetic Supplies: Updates to the List of Contracted Diabetic Testing Supplies, Effective July, 1, 2025
- June 1, 2025: Updates to the List of Contracted Enteral Nutrition Products Effective July 1, 2025
- June 1, 2025: Diabetic Supplies Updates: Updates to the List of Contracted Continuous Glucose Monitoring Systems, Effective July 1, 2025
- June 1, 2025: Medical Supplies: Updates to the List of Contracted Pen Needles, Effective July 1, 2025
- June 1, 2025: Medi-Cal Rx Monthly Bulletin for June
- May 1, 2025: Updates to the List of Contracted COVID-19 Antigen Tests, Effective June 1, 2025
- May 1, 2025: Medi-Cal Rx Monthly Bulletin for May
- April 15, 2025: Medi-Cal Rx Secured Provider Portal Password Reminders
- April 1, 2025: Updates to the List of Contracted Enteral Nutrition Products, Effective May 1, 2025
- April 1, 2025: Loading Dose Quantity Policy Updated in the Medi-Cal Rx Contract Drugs List
- April 1, 2025: Medi-Cal Rx Monthly Bulletin for April
- March 28, 2025: Medi-Cal Rx Provider Portal Enhancement: Prescriber NPI Validation
- March 25, 2025: 30-Day Countdown: Completion of Pediatric Integration of Members 21 Years of Age and Younger
- March 3, 2025: Coming Soon: Completion of Pediatric Integration of Members 21 Years of Age and Younger
- March 3, 2025: 30-Day Countdown: Medi-Cal Rx Contract Drugs List Loading Dose Quantity Policy Update
- March 1, 2025: Updates to the List of Contracted Enteral Nutrition Products, Effective April 1, 2025
- March 1, 2025: Changes to the Medi-Cal Rx Contract Drugs List
- March 1, 2025: Updates to the Medi-Cal Rx Provider Manual
- Feb. 1, 2025: Changes to the Medi-Cal Rx Contract Drugs List
- Feb. 1, 2025: Updates to the Medi-Cal Rx Provider Manual
- Feb. 1, 2025: Medi-Cal Rx Monthly Bulletin for February
- Jan. 31, 2025: Now Active - Pediatric Integration for New Start Therapies and CCS Panel Authority
- Jan. 31, 2025: Updated: Medi-Cal Rx Enteral Nutrition Prior Authorization Request Form
- Jan. 22, 2025: Now Available: CCS Panel Authority Policy Exclusions on the Medi-Cal Rx Approved NDC List
- Jan. 1, 2025: Updates to the List of Contracted COVID-19 Antigen Tests
- Jan. 1, 2025: Updates to the List of Contracted Enteral Nutrition Products
- Jan. 1, 2025: Updates to the List of Contracted Continuous Glucose Monitoring (CGM) Systems
- Jan. 1, 2025: Updates to the List of Contracted Pen Needles
- Jan. 1, 2025: Updates to the List of Contracted Disposable Insulin Delivery Devices
- Jan. 1, 2025: Updates to the List of Contracted Diabetic Testing Supplies
- Jan. 1, 2025: Medi-Cal Rx Monthly Bulletin for January
- Jan. 1, 2025: 30-Day Countdown: Maximum Quantity Limits for Specialty Infant Enteral Nutrition Products
- Jan. 1, 2025: Medical Supplies: Updates to the List of Contracted Blood Pressure Monitors and Cuffs, Effective Feb. 1, 2025
- Jan. 1, 2025: Updates to the Medi-Cal Rx Provider Manual
- Jan. 1, 2025: Changes to the Medi-Cal Rx Contract Drugs List
- Dec. 31, 2024: 30-Day Countdown: Pediatric Integration of Members 21 Years of Age and Younger
- Dec. 23, 2024: Extension of Post-PREP COVID-19 Vaccine Policy Update
- Dec. 1, 2024: Updates to the List of Contracted Pen Needles, Effective Jan. 1, 2025
- Dec. 1, 2024: Updates to the List of Contracted Enteral Nutrition Products, Effective Jan. 1, 2025
- Dec. 1, 2024: Updates to the List of Contracted Disposable Insulin Delivery Devices, Effective Jan. 1, 2025
- Dec. 1, 2024: Updates to the List of Contracted Diabetic Testing Supplies, Effective January 1, 2025 and March 1, 2025
- Dec. 1, 2024: Updates to the List of Contracted Continuous Glucose Monitoring (CGM) System, Effective Jan. 1, 2025
- Dec. 1, 2024: Updates to the List of Contracted COVID-19 Tests, Effective Jan. 1, 2025
- Dec. 1, 2024: Medi-Cal Rx Monthly Bulletin for December
- Nov. 8, 2024: Reminder: Dual Eligible Special Needs Plan Deeming Periods
- Nov. 1, 2024: Medi-Cal Rx Monthly Bulletin for November
- Oct. 31, 2024: 90-Day Countdown: Pediatric Integration of Members 21 Years of Age and Younger
- Oct. 3, 2024: Deactivation of Override Code “55555” for All Drugs/Products – Medi-Cal Rx Program Integrity Update
- Oct. 1, 2024: Changes to the Medi-Cal Rx Contract Drugs List
- Oct. 1, 2024: Changes to the Medi-Cal Rx Contract Drugs List – Over-the-Counter Drugs and Cough/Cold Preparations
- Oct. 1, 2024: Changes to the Medi-Cal Rx Pharmacy Reimbursable Physician Administered Drugs
- Oct. 1, 2024: Changes to the Medi-Cal Rx Family Planning, Access, Care, and Treatment Pharmacy Formulary
- Oct. 1, 2024: Updates to the Medi-Cal Rx Provider Manual
- Oct. 1, 2024: Medi-Cal Rx Monthly Bulletin for October
- Sept. 30, 2024: Medi-Cal Rx Provider Portal Prior Authorization Submission Update: Member Validation Enhancement
- Sept. 24, 2024: UAC URL Update
- Sept. 24, 2024: Pemgarda™ (pemivibart) Now a Medi-Cal Rx Benefit
- Sept. 1, 2024: COVID-19 Antigen Over-the-Counter Test Coverage Updates, Effective Oct. 1, 2024
- Sept. 1, 2024: Updates to the List of Contracted Enteral Nutrition Products, Effective Oct. 1, 2024
- Sept. 1, 2024: Medi-Cal Rx Monthly Bulletin for September
- Aug. 12, 2024: Vaccines For Children Program: Medi-Cal Reference Guide
- Aug. 1, 2024: Medi-Cal Rx Monthly Bulletin for August
- Aug. 1, 2024: Updates to the Medi-Cal Rx Provider Manual
- July 24, 2024: Reminder: Quantity Limit Restrictions for Anti-Obesity Preparations
- July 1, 2024: Medi-Cal Rx Monthly Bulletin for July
- July 1, 2024: Updates to the Medi-Cal Rx Provider Manual
- June 14, 2024: Code I Diagnosis Requirement for Chronic Weight Management
- June 10, 2024: New Medi-Cal Rx Web Portal Resource Pages: FDA Drug Recall Notifications
- June 1, 2024: Enteral Nutrition Updates to the List of Contracted Enteral Nutrition Products, Effective Sept. 1, 2024
- June 1, 2024: Medi-Cal Rx Monthly Bulletin for June
- May 23, 2024: Updates to Continuous Monitoring and Disposable Insulin Delivery Devices Quantity Limits, Effective June 7, 2024
- May 20, 2024: Member Eligibility Lookup Tool - Enhanced Functionality
- May 15, 2024: Medi-Cal Rx Provider Portal Troubleshooting and Support
- May 1, 2024: Availability of Extencilline on the Medi-Cal Rx Contract Drugs List
- May 1, 2024: Medi-Cal Rx Monthly Bulletin for May
- April 23, 2024: How to Address Reject Code 80 - Diagnosis Code Submitted Does Not Meet Drug Coverage Criteria
- April 1, 2024: Medi-Cal Rx Monthly Bulletin for April
- April 1, 2024: Diabetic Test Strips and Lancets: Updates to the Code I Diagnosis and Quantity Limit Restrictions
- March 29, 2024: Opill Available Over-the-Counter Under Medi-Cal Rx Prescription
- March 29, 2024: 30-Day Countdown: Implementation of Reject Code 80 - Diagnosis Code Submitted Does Not Meet Drug Coverage Criteria
- March 1, 2024: Medi-Cal Rx Monthly Bulletin for March
- Feb. 1, 2024: Medi-Cal Rx Monthly Bulletin for February
- Jan. 2, 2024: Updates to the Medi-Cal Rx Provider Manual
- Jan. 2, 2024: Medical Foods Are Not a Covered Benefit
- Jan. 2, 2024: Medi-Cal Rx Monthly Bulletin for January
- Jan. 1, 2024: Updates to Diabetic Testing Supplies 100-Count LifeScan OneTouch Verio Test Strips No Longer Covered
- Dec. 15, 2023: Medical Supplies Reminder: Updates to Diabetic Testing Supplies 100-Count LifeScan, Inc.’s OneTouch Verio Test Strips Will No Longer Be Contracted, Effective Jan. 1, 2024
- Dec. 8, 2023: Update: Deferral Response Method via Medi-Cal Rx Provider Portal
- Dec. 1, 2023: Updates to the List of Contracted Enteral Nutrition Products, Effective Jan. 1, 2024 and April 1, 2024
- Dec. 1, 2023: Medical Supplies Update: Updates to List of Contracted Self-Monitoring Blood Glucose Systems (Glucometers), Control Solutions, and Lancing Devices – Effective Jan. 1, 2024
- Dec. 1, 2023: Medical Supplies Update: Updates to Diabetic Testing Supplies, Effective Jan. 1, 2024
- Dec. 1, 2023: Medical Supplies Updates: Updates to Contracted Pen Needles, Insulin Syringes, and Sterile Syringes with Needles (Non-Insulin), Effective Jan. 1, 2024
- Dec. 1, 2023: Updates to the Medi-Cal Rx Provider Manual
- Dec. 1, 2023: Medi-Cal Rx Monthly Bulletin for December
- Nov. 29, 2023: Commercial COVID-19 Vaccine Coverage for Children
- Nov. 8, 2023: Reminder: Reinstatement of Brand Medically Necessary Prior Authorization Request Requirements for DAW 1 Claims
- Nov. 3, 2023: Deactivation of Override Code “55555” for Select Drugs/Products – Medi-Cal Rx Program Integrity Update
- Nov. 1, 2023: 30-Day Countdown: Changes to Continuous Glucose Monitoring Systems Coverage Criteria and Prior Authorization Bundling
- Nov. 1, 2023: How to Resolve Reject Code A6 for Orally Administered Enteral Nutrition Claims
- Nov. 1, 2023: Medi-Cal Rx Monthly Bulletin for November
- Nov. 1, 2023: Changes to the Medi-Cal Rx Pharmacy Reimbursable Physician Administered Drugs
- November 1, 2023: Updates to the Medi-Cal Rx Provider Manual
- Oct. 29, 2023: Updates to the Medi-Cal Rx Web Portal Appearance and Resources
- Oct. 25, 2023: Reminder: Reject Code 76 Point-of-Sale Messaging
- Oct. 24, 2023: Reminder: Quantity Limit Restrictions for Common Continuous Glucose Monitoring Devices
- Oct. 17, 2023: Reject Code 80 (Diagnosis) – Implementation Date Postponed
- Oct. 10, 2023: 30-Day Countdown: Phase IV, Lift 4: End of Transition Policy
- Oct. 6, 2023: Effective Oct. 13, 2023, Medi-Cal Rx Will Reinstate Quantity Restriction Edits
- Oct. 5, 2023: Diabetic Supplies: Updates to the Quantity and Fill Limitations for Diabetic Testing Supplies
- Oct. 4, 2023: Updates to Enteral Nutrition Prescription Requirements
- Oct. 3, 2023: Respiratory Syncytial Virus (RSV) Vaccines Arexvy™ and Abrysvo™ Now on the Contract Drugs List
- Oct. 1, 2023: COVID-19 Antigen Over-the-Counter Test Coverage Updates, Effective Nov. 1, 2023
- Oct. 1, 2023: Medical Supplies: Future Changes to Continuous Glucose Monitoring Systems Coverage Criteria and Prior Authorization Bundling
- Oct. 1, 2023: Diabetic Supplies: Updates to the Dexcom G7® Continuous Glucose Monitoring Sensor Package Size Description, Effective Oct. 1, 2023
- Oct. 1, 2023: Medi-Cal Rx Monthly Bulletin for October
- Oct. 1, 2023: Changes to the Medi-Cal Rx Pharmacy Reimbursable Physician Administered Drugs
- Sept. 22, 2023: Update: Reimbursement for New Commercial COVID-19 Vaccines
- Sept. 22, 2023: Now Available: Medi-Cal Rx Enteral Nutrition Prior Authorization Request Form
- Sept. 22, 2023: Enteral Nutrition Shortages
- Sept. 21, 2023: Reimbursement for New Commercial COVID-19 Vaccines
- Sept. 13, 2023: 30-Day Countdown: Phase IV, Lift III: Reinstatement of Reject Code 76: Plan Limitations Exceeded
- Sept. 11, 2023: Coming Soon: Commercialization of COVID-19 Vaccines
- Sept. 5, 2023: Reinstatement of the Labeler Code Restriction for Brand Name Suboxone
- Sept. 1, 2023: Diabetic Supplies Update: Changes to Continuous Glucose Monitoring Systems Policy, Effective October 1, 2023
- Sept. 1, 2023: Medical Supplies Update: Updates to Contracted Diabetic Test Strips and Lancets List, Effective October 1, 2023
- Sept. 1, 2023: Maximum Allowable Ingredient Cost 30-Day Pharmacy Provider Notice
- Sept. 1, 2023: Medi-Cal Rx Monthly Bulletin for September
- Aug. 23, 2023: 30-Day Countdown: Reinstatement of Cost Ceiling and Prior Authorization for Enteral Nutrition and Specific Standard Therapeutic Classes
- Aug. 22, 2023: Lift of Labeler Code Restriction for Truvada
- August 21, 2023: Recommencement of Pharmacy Retroactive Claim Adjustments: Publication of Updated Frequently Asked Questions (FAQs)
- August 17, 2023: Temporary Lift of Labeler Code Restriction for Suboxone Film
- Aug. 16, 2023: Enteral Nutrition for Members 22 Years of Age and Older: New Start Prior Authorization Reminders
- Aug. 9, 2023: 90-Day Countdown: Reinstatement of Prior Authorization Requirements for Enteral Nutrition Claims for Members 22 Years of Age and Older
- Aug. 1, 2023: Prior Authorization Submission Using the Electronic Health Record to Initiate an Electronic Prior Authorization Request via CoverMyMeds®
- Aug. 1, 2023: Medi-Cal Rx Monthly Bulletin for August
- July 26, 2023: Reminder: Medi-Cal Rx Billing Policy for Physician Administered Drugs
- July 3, 2023: 30-Day Countdown: Phase IV, Lift 1: Reinstatement of Claim Edits for Age, Gender, and Labeler Code Restrictions for Beneficiaries 22 Years of Age and Older
- June 23, 2023: 90-Day Countdown: Reinstatement of Prior Authorization Requirements for Enteral Nutrition Products for Members 22 Years of Age and Older
- June 20, 2023: Drug Lookup Tool – Enhanced Functionality
- June 1, 2023: Updates to the List of Contracted Personal Blood Pressure Monitoring Devices and Cuffs
- June 1, 2023: Medical Supplies Update: Updates to Diabetic Blood Glucose Test Strips and Lancets Quantity Limits, Effective July 1, 2023
- June 1, 2023: Medi-Cal Rx Monthly Bulletin for June
- May 26, 2023: Pharmacy Locator Tool – Enhanced Functionality
- May 23, 2023: 30-Day Countdown – Phase III, Lift 4: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older
- May 12, 2023: Billing Tips: Non-Covered Medical Supplies
- May 12, 2023: List of Medications Eligible for an Extended Duration Prior Authorization
- May 2, 2023: Refill of Continuous Glucose Monitoring (CGM) Supplies
- May 1, 2023: Discontinuation of the COVID-19 Uninsured Group Program
- May 1, 2023: Reinstatement of the Medi-Cal Rx Controlled Substance Policy on Buprenorphine Products
- May 1, 2023: Updated: Appendix H – List of Physician Administered Drugs (PADs) with Reject Code 816
- April 24, 2023: Policy Reminder: Limitations on Coverage of Certain Drugs or Classes of Drugs
- April 21, 2023: NCPDP Reject Code 76: Continuous Glucose Monitor (CGM) Supplies
- April 19, 2023: 30-Day Countdown – Phase III, Lift 3: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older
- April 11, 2023: Medication Abortion: Coverage of Misoprostol-Only Regimen
- March 24, 2023: Prior Authorization Submission in Advance of the Retirement of the Transition Policy – Processing Issue Resolved
- March 22, 2023: Extended Duration Prior Authorizations for Maintenance Medications
- March 21, 2023: 30-Day Countdown – Phase III, Lift 2: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older
- March 10, 2023: Submitting Prior Authorization Requests in Advance of Retirement of the Transition Policy
- Feb. 23, 2023: 30-Day Countdown – Phase III, Lift 1: Retirement of the Transition Policy for Beneficiaries 22 Years of Age and Older
- Jan. 24, 2023: 30-Day Countdown – Reinstatement of Prior Authorization Requirements for 46 Drug Classes Including Medical Supplies
- Jan. 24, 2023: Medi-Cal Rx Phase II and Preparing for Phase III Transition Policy Retirement Frequently Asked Questions (FAQs)
- Jan. 19, 2023: Medical Supplies: How to Prepare for Retirement of the Transition Policy
Pharmacy Newsletters, DUR Educational Articles and FDA Communications
- Summer Newsletter, June 2025
- DUR Educational Article, May 30, 2025: Pharmacists Furnishings of Nicotine Replacement Therapy Products - May 2025
- DUR Educational Article, April 7, 2025: Measles Vaccination Prevents Outbreaks, Protects Californians - April 2025
- DUR Educational Article, Feb. 20, 2025: 2024 Immunization Update: COVID-19, Influenza, RSV, Pneumococcal Polio, Meningococcal, HiB, HepB, and Mpox
- Winter Newsletter, March 2025
- DUR Educational Article, Feb. 20, 2025: 2024 Immunization Update: COVID-19, Influenza, RSV, Pneumococcal Polio, Meningococcal, HiB, HepB, and Mpox
- Fall Newsletter, November 2024
- DUR Educational Article, Sept. 17, 2024: Screening, Diagnosis, and Treatment of Chronic Hepatitis C Virus Infection - September 2024
- DUR Educational Article, Aug. 23, 2024: Risks of Concomitant Statin Therapy with Gemfibrozil - August 2024
- DUR Educational Article, May 28, 2024: Aspirin for Primary Prevention of Cardiovascular Disease - May 2024
- DUR Educational Article, Jan. 29, 2024: Alternatives to Diphenhydramine for Older Adults - Updated March 2024
- Summer Newsletter, July 2024
- Spring Newsletter, April 2024
- Winter Newsletter, February 2024
- Fall Newsletter, Nov. 2023
- DUR Educational Article, Nov. 1, 2023: 2023 Immunization Update: COVID-19, Influenza, RSV, HepB, Pneumococcal, HPV, Polio, Mpox, and MMR - November 2023
- DUR Educational Article, Aug. 30, 2023: No Added Benefit from Concomitant Use of GLP-1 Agonists and DPP-4 Inhibitors
- DUR Educational Article, Aug. 16, 2023: New Resources Available for Perinatal Mental Health Conditions
- DUR Educational Article, June 30, 2023: Updated Guidance by the CDC and FDA for Prescribing Opioids
- DUR Educational Article, June 30, 2023: FDA Approves First Over-the-Counter Naloxone Nasal Spray
- Summer Newsletter, July 2023
- DUR Educational Article, May 2, 2023: Clinical Review: Management of Acute Postpartum Pain - May 2023
- Spring Newsletter, April 2023
- DUR Educational Article, Jan. 27, 2023: Risks to Patients Exposed to Xylazine in Illicit Drugs
- DUR Educational Article, Jan. 27, 2023: Improving the Quality of Care: Treatment of Latent Tuberculosis Infection
- DUR Educational Article, Jan. 27, 2023: 2022 Immunization Update: Mpox, HepB, Influenza, COVID-19, Pneumococcal, Zoster
- DUR Educational Article, Jan. 20, 2023: Removal of DATA-Waiver (X-Waiver) Requirement
- Winter Newsletter, Dec. 2020
- Fall Newsletter, Sept. 2020
- DUR Bulletin, Aug. 31, 2020: 2020 Standards of Care for Treatment of Type 2 Diabetes
- Summer Newsletter, June 2020
- DUR Bulletin, May 29, 2020: Reproductive Health in Rheumatic and Musculoskeletal Diseases
- DUR Bulletin, April 30, 2020: Update of Risks Associated with Use of Fluoroquinolones
- DUR Bulletin, April 30, 2020: Withdrawal of All Ranitidine Products
- DUR Bulletin, March 31, 2020: Mental Health Side Effects from Montelukast
- Spring Newsletter, March 2020
- DUR Bulletin, Dec. 31, 2019: Risks Associated with Use of Gabapentin
- Winter Newsletter, Dec. 2019
- DUR Bulletin, Oct. 31, 2019: New Global Guidelines for the Treatment of Asthma
- DUR Bulletin, Sept. 27, 2019: Flu, HepA, HPV, Measles, CA School Requirements
- Fall Newsletter, Sept. 2019
- DUR Bulletin, Aug. 30, 2019: Concomitant Anticholinergic and Antipsychotic Use
- DUR Bulletin, June 28, 2019: Sleep Behavior Risks with Select Sleep Aids
- Summer Newsletter, June 2019
- DUR Bulletin, April 30, 2019: Risks with Sudden Discontinuation of Opioids
- DUR Bulletin, March 29, 2019: Updated Adverse Effects from Fluoroquinolones
- Spring Newsletter, March 2019
- DUR Bulletin, Feb. 28, 2019: Morphine Equivalent Daily Dose
- DUR Bulletin, Jan. 31, 2019:New Naloxone Regulations Effective on January 1, 2019
- DUR Bulletin, Sept. 28, 2018: Flu, Tdap, HepB, Zoster, MMR, Adult Vaccines
- DUR Bulletin, Sept. 28, 2018: Mandatory Use of CURES 2.0 Begins October 2, 2018
- Summer Newsletter, Aug. 2018
- DUR Bulletin, March 30, 2018: Pharmacist Furnishing Nicotine Replacement Products
- DUR Bulletin, Feb. 28, 2018: New Age Limit for Opioid Cough and Cold Medicines